COWAN CHAD (Chief Scientific Officer) reported 1 transaction at CENTURY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/13/2026ACC: 0002039294-26-000006
Officer· Chief Scientific Officer
Since Mar 2026
-1.43K
Net shares
Net seller
$3.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.43K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.43K
Price / share
$2.73
Trade value
$3.91K
% of position
0.1%
3/11/2026
1.18M→1.18M
Total
Net shares
−1.43K
Net value
-$3.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | F · Tax Withholding | −1.43K | $2.73 | $3.91K | 0.1% | 1.18M | 1.18M |
| Total | −1.43K | -$3.91K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.70K
Total
10.70K indirect10.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.70K | Indirect |
| Total | 10.70K | 10.70K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported